Hepatobiliary effects and safety of tirzepatide: A systematic review and meta‐analysis

Documenti analoghi

• Impact of glucagon‐like peptide‐1 receptor agonism‐based therapies on limb outcomes in peripheral artery disease and type 2 diabetes: An updated systematic review and meta‐analysis
  di: Deep Dutta, et al.
  Pubblicazione: (2025)
• Safety and effectiveness of tirzepatide during Ramadan fasting: Real‐world evidence from patients with type 2 diabetes in Bangladesh
  di: Muhammad Hafizur Rahman, et al.
  Pubblicazione: (2025)
• Impact of Real Time, Flash and Retrospective Continuous Glucose Monitoring on Feto‐Maternal Outcomes in Women With Gestational Diabetes and Pre‐Gestational Diabetes: A Systematic Review and Meta‐Analysis With Trial Sequential Analysis of Randomized Controlled Trials
  di: Deep Dutta, et al.
  Pubblicazione: (2026)
• Comparative efficacy and safety of weekly tirzepatide versus weekly insulin in type 2 diabetes: A network meta‐analysis of randomized clinical trials
  di: Hazem Ayesh, et al.
  Pubblicazione: (2024)
• Real‐world effectiveness and safety of tirzepatide in Japanese patients with type 2 diabetes: A multi‐site retrospective study
  di: Yusuke Minakata, et al.
  Pubblicazione: (2026)